http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497280-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0dab163938573604b8cd2cbcbbd3d49d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_885b4300141b9dc01ee895c43e10ed8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af41892422640152790731dcabd414ae
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
filingDate 2008-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49b913e6ecfbd8204298551ed1e0e6f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce611434fdf1caedaac70cd4ada031b
publicationDate 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8497280-B2
titleOfInvention Medicinal compositions comprising buprenorphine and nalmefene
abstract An analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount nalmefene such that the ratio by weight of buprenorphine to nalmefene delivered to or reaching the plasma of a patient is in the range 22.6:1 to 40:1. The analgesic action of the buprenorphine is potentiated by the low dose of nalmefene. Also provided are a method of treatment of pain and the use of nalmefene and buprenorphine for the manufacture of a medicament.
priorityDate 2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003004178-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226929186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127737058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449251734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829

Total number of triples: 50.